Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191
ROVULUM 2 mg film coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. ROVULUM is a white, round, biconvex film-coated tablet embossed with “2” on one side. |
Each film-coated tablet of ROVULUM contains 2 mg of dienogest.
Contains sugar: Lactose monohydrate 57,2 mg.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dienogest |
Dienogest is a nortestosterone derivative with no androgenic but rather an antiandrogenic activity of approximately one third of that of cyproterone acetate. Dienogest binds to the progesterone receptor of the human uterus with only 10% of the relative affinity of progesterone. |
| List of Excipients |
|---|
|
Cottonseed oil hydrogenated |
ROVULUM is packed in PVC/PVDC/Aluminium blister strips. The blister strips are packed in printed cartons. Pack size of 28 film-coated tablets.
PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191
52/21.8.2/0336
14 June 2022
| Drug | Countries | |
|---|---|---|
| ROVULUM | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
